Athira Pharma, Inc. ( ATHA) - Stock Earnings
Stock symbol ATHA is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker ATHA was renamed to
LONA
effective 2026-01-12.
ATHA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -29.6 million USD | — USD |
| 2023Q3 | -33.0 million USD | — USD |
| 2023Q4 | -27285 USD | — USD |
ATHA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -54.4 million USD | 0 USD |
| 2022 | -87.3 million USD | 0 USD |
| 2023 | -117672 USD | — USD |
ATHA
Price: $6.75
52 week price:
Earnings Per Share: -9.67 USD
P/E Ratio: -0.68
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 290900
Market Capitalization: 26.0 million